Neurowave Medical Tech LLC is categorized under Biotherapeutics in Chicago, IL and active since 2006.
Neurowave Medical Tech LLC was established in 2006, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Biotherapeutics business, which does work in the BOTH market, and is classified as a Biotherapeutics, under code number 4234502 by the NAICS.
If you are seeking more information, feel free to contact Farhan Hussain at the company’s single location by writing to 200 East Randolph St # 2200, Chicago, Illinois IL 60601 or by phoning (312) 334-2505. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Neurowave Medical Tech LLC |
Contact Person: | Farhan Hussain |
Address: | 200 East Randolph St # 2200, Chicago, Illinois 60601 |
Phone Number: | (312) 334-2505 |
Website Address: | neurowavemedical.com |
Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
Founded: | 2006 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B & B2C |
Business Category: | Biotherapeutics |
SIC Code: | 5122 |
NAICS Code: | 4234502 |
Share This Business: |
Neurowave Medical Tech LLC was started in 2006 to provide professional Biotherapeutics under the SIC code 5122 and NAICS code 4234502. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Farhan Hussain for inquiries that concern Neurowave Medical Tech LLC by calling the company number (312) 334-2505, as your correspondence is most welcome. Additionally, the physical location of the single location of Neurowave Medical Tech LLC can be found at the coordinates 41.884531,-87.622289 as well as the street address 200 East Randolph St # 2200 in Chicago, Illinois 60601.
For its online presence, you may visit Neurowave Medical Tech LLC’s website at neurowavemedical.com and engage with its social media outlets through on Twitter and on Facebook.